Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Interaction between Fexofenadine and CYP Phenotyping Probe Drugs in Geneva Cocktail.

Bosilkovska M, Magliocco G, Desmeules J, Samer C, Daali Y.

J Pers Med. 2019 Oct 2;9(4). pii: E45. doi: 10.3390/jpm9040045.

2.

Effects of Switching to a Heat-Not-Burn Tobacco Product on Biologically Relevant Biomarkers to Assess a Candidate Modified Risk Tobacco Product: A Randomized Trial.

Lüdicke F, Ansari SM, Lama N, Blanc N, Bosilkovska M, Donelli A, Picavet P, Baker G, Haziza C, Peitsch M, Weitkunat R.

Cancer Epidemiol Biomarkers Prev. 2019 Nov;28(11):1934-1943. doi: 10.1158/1055-9965.EPI-18-0915. Epub 2019 Jul 3.

PMID:
31270101
3.

Evaluation of Biological and Functional Changes in Healthy Smokers Switching to the Tobacco Heating System 2.2 Versus Continued Tobacco Smoking: Protocol for a Randomized, Controlled, Multicenter Study.

Ansari SM, Lama N, Blanc N, Bosilkovska M, Donelli A, Picavet P, Baker G, Haziza C, Lüdicke F.

JMIR Res Protoc. 2018 Aug 24;7(8):e11294. doi: 10.2196/11294.

4.

Phenotypic Assessment of Drug Metabolic Pathways and P-Glycoprotein in Patients Treated With Antidepressants in an Ambulatory Setting.

Lloret-Linares C, Bosilkovska M, Daali Y, Gex-Fabry M, Heron K, Bancila V, Michalopoulos G, Perroud N, Richard-Lepouriel H, Aubry JM, Desmeules J, Besson M.

J Clin Psychiatry. 2018 Mar/Apr;79(2). pii: 16m11387. doi: 10.4088/JCP.16m11387.

PMID:
29570971
5.

Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling Method.

Bosilkovska M, Samer C, Déglon J, Thomas A, Walder B, Desmeules J, Daali Y.

Basic Clin Pharmacol Toxicol. 2016 Sep;119(3):284-90. doi: 10.1111/bcpt.12586. Epub 2016 Apr 25.

6.

Severe Vincristine-induced Neuropathic Pain in a CYP3A5 Nonexpressor With Reduced CYP3A4/5 Activity: Case Study.

Bosilkovska M, Ing Lorenzini K, Uppugunduri CR, Desmeules J, Daali Y, Escher M.

Clin Ther. 2016 Jan 1;38(1):216-20. doi: 10.1016/j.clinthera.2015.10.017. Epub 2015 Nov 10.

PMID:
26565076
7.

Geneva cocktail for cytochrome p450 and P-glycoprotein activity assessment using dried blood spots.

Bosilkovska M, Samer CF, Déglon J, Rebsamen M, Staub C, Dayer P, Walder B, Desmeules JA, Daali Y.

Clin Pharmacol Ther. 2014 Sep;96(3):349-59. doi: 10.1038/clpt.2014.83. Epub 2014 Apr 10.

8.

Incorporation of flurbiprofen in a 4-drug cytochrome p450 phenotyping cocktail.

Bosilkovska M, Clément M, Dayer P, Desmeules J, Daali Y.

Basic Clin Pharmacol Toxicol. 2014 Nov;115(5):465-6. doi: 10.1111/bcpt.12231. Epub 2014 Apr 25. No abstract available.

9.

Simultaneous LC-MS/MS quantification of P-glycoprotein and cytochrome P450 probe substrates and their metabolites in DBS and plasma.

Bosilkovska M, Déglon J, Samer C, Walder B, Desmeules J, Staub C, Daali Y.

Bioanalysis. 2014 Jan;6(2):151-64. doi: 10.4155/bio.13.289.

PMID:
24423593
10.

Real-time monitoring of exhaled drugs by mass spectrometry.

Berchtold C, Bosilkovska M, Daali Y, Walder B, Zenobi R.

Mass Spectrom Rev. 2014 Sep-Oct;33(5):394-413. doi: 10.1002/mas.21393. Epub 2013 Nov 22. Review.

PMID:
24272872
11.

Analgesics in patients with hepatic impairment: pharmacology and clinical implications.

Bosilkovska M, Walder B, Besson M, Daali Y, Desmeules J.

Drugs. 2012 Aug 20;72(12):1645-69. doi: 10.2165/11635500-000000000-00000.

PMID:
22867045
12.

Ritonavir inhibits the two main prasugrel bioactivation pathways in vitro: a potential drug-drug interaction in HIV patients.

Daali Y, Ancrenaz V, Bosilkovska M, Dayer P, Desmeules J.

Metabolism. 2011 Nov;60(11):1584-9. doi: 10.1016/j.metabol.2011.03.015. Epub 2011 May 6.

PMID:
21550074

Supplemental Content

Loading ...
Support Center